About two years ago, Bristol Myers Squibb bought a manufacturing plant in the Chicago suburbs from Novartis, with plans to make viral vectors for BMS’ CAR T therapeutics there. Now, BMS is shutting the plant down as part of BMS’ ongoing cost-cutting spree. The company is laying off 133 employees, with the first layoff date on June 1, according to a Worker Retraining Notification Act notice.
